KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 58, Issue 9, Pages 5060-5067
Publisher
American Society for Microbiology
Online
2014-06-10
DOI
10.1128/aac.02727-13
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Type II Fatty Acid Biosynthesis Is Essential for Plasmodium falciparum Sporozoite Development in the Midgut of Anopheles Mosquitoes
- (2013) Ben C. L. van Schaijk et al. EUKARYOTIC CELL
- Targeting Plasmodium PI(4)K to eliminate malaria
- (2013) Case W. McNamara et al. NATURE
- Quinolone-3-Diarylethers: A New Class of Antimalarial Drug
- (2013) A. Nilsen et al. Science Translational Medicine
- The Spiroindolone Drug Candidate NITD609 Potently Inhibits Gametocytogenesis and Blocks Plasmodium falciparum Transmission to Anopheles Mosquito Vector
- (2012) J. C. van Pelt-Koops et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Imidazolopiperazines: Lead Optimization of the Second-Generation Antimalarial Agents
- (2012) Advait Nagle et al. JOURNAL OF MEDICINAL CHEMISTRY
- Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study
- (2012) Aung Pyae Phyo et al. LANCET
- A framework for assessing the risk of resistance for anti-malarials in development
- (2012) Xavier C Ding et al. MALARIA JOURNAL
- A Major Genome Region Underlying Artemisinin Resistance in Malaria
- (2012) I. H. Cheeseman et al. SCIENCE
- The Activities of Current Antimalarial Drugs on the Life Cycle Stages of Plasmodium: A Comparative Study with Human and Rodent Parasites
- (2012) Michael Delves et al. PLOS MEDICINE
- Use of a Selective Inhibitor To Define the Chemotherapeutic Potential of the Plasmodial Hexose Transporter in Different Stages of the Parasite's Life Cycle
- (2011) Ksenija Slavic et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Phosphoproteomes of Plasmodium falciparum and Toxoplasma gondii Reveal Unusual Adaptations Within and Beyond the Parasites' Boundaries
- (2011) Moritz Treeck et al. Cell Host & Microbe
- Dihydroartemisinin-Piperaquine Versus Chloroquine in the Treatment of Plasmodium vivax Malaria in Thailand: A Randomized Controlled Trial
- (2011) A. P. Phyo et al. CLINICAL INFECTIOUS DISEASES
- Target identification and validation of novel antimalarials
- (2011) Case McNamara et al. Future Microbiology
- A High-Throughput Screen Targeting Malaria Transmission Stages Opens New Avenues for Drug Development
- (2011) Kathrin Buchholz et al. JOURNAL OF INFECTIOUS DISEASES
- Imidazolopiperazines: Hit to Lead Optimization of New Antimalarial Agents
- (2011) Tao Wu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Towards an In Vitro Model of Plasmodium Hypnozoites Suitable for Drug Discovery
- (2011) Laurent Dembele et al. PLoS One
- Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue
- (2011) S. H. Adjalley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery
- (2011) S. Meister et al. SCIENCE
- A Research Agenda for Malaria Eradication: Drugs
- (2011) PLOS MEDICINE
- Sulfadoxine–pyrimethamine impairs Plasmodium falciparum gametocyte infectivity and Anopheles mosquito survival
- (2010) Aminatou Kone et al. INTERNATIONAL JOURNAL FOR PARASITOLOGY
- Protein Export Marks the Early Phase of Gametocytogenesis of the Human Malaria ParasitePlasmodium falciparum
- (2010) Francesco Silvestrini et al. MOLECULAR & CELLULAR PROTEOMICS
- Thousands of chemical starting points for antimalarial lead identification
- (2010) Francisco-Javier Gamo et al. NATURE
- Chemical genetics of Plasmodium falciparum
- (2010) W. Armand Guiguemde et al. NATURE
- Establishment of an In Vitro Assay for Assessing the Effects of Drugs on the Liver Stages of Plasmodium vivax Malaria
- (2010) Rana Chattopadhyay et al. PLoS One
- That Was Then But This Is Now: Malaria Research in the Time of an Eradication Agenda
- (2010) S. H. I. Kappe et al. SCIENCE
- Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar
- (2010) Jean-Paul Guthmann et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia
- (2009) Richard J Maude et al. MALARIA JOURNAL
- Artemisinin Resistance inPlasmodium falciparumMalaria
- (2009) Arjen M. Dondorp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Determinants of In Vitro Drug Susceptibility Testing of Plasmodium vivax
- (2008) B. Russell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- SOAP: short oligonucleotide alignment program
- (2008) R. Li et al. BIOINFORMATICS
- The role of anti-malarial drugs in eliminating malaria
- (2008) Nicholas J White MALARIA JOURNAL
- Evidence of Artemisinin-Resistant Malaria in Western Cambodia
- (2008) Harald Noedl et al. NEW ENGLAND JOURNAL OF MEDICINE
- In silicoactivity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen
- (2008) David Plouffe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A combined transcriptome and proteome survey of malaria parasite liver stages
- (2008) A. S. Tarun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started